NCT00294944撤回3 期
The Effectiveness of Idazoxan in Treating TRD
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 撤回
- 试验地点
- 1
研究概览
简要总结
Assessing the effectiveness of Idazoxan as a treatment for depressive patients who did not respond to treatment with SSRI
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •MDD patients
- •Did not respond to at least one treatment of 4-6 weeks of SSRI in adequate dose
- •In or out patients
排除标准
- •Psychotic symptoms
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Effect of mirtazapine and sertraline on BDI score and their link with serotonin transporter gene polymorphism in patients of Major depressive disorders .CTRI/2018/08/015172niversity College of Medical Sciences
进行中（未招募）
不适用
A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)HER2-positive Gastroesophageal Junction AdenocarcinomaHER2-positive Advanced Gastric CancerNCT05993234Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company257
Unknown
4 期
A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.Major Depressive DisorderBipolar DisorderNCT00335205Sheba Medical Center60
招募中
不适用
DESTINY Breast Respond HER2-(Ultra)Low EuropeHER2-(Ultra)Low Expressing Breast CancerMetastatic Breast CancerHER2-low Expressing Breast CancerUnresectable Breast CancerNCT05945732Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2,295
已完成
1 期
Doxazosin for Psychostimulant DependenceMethamphetamine or Cocaine DependenceNCT01371851University of Arkansas22